Variant report
Variant | nsv965799 |
---|---|
Chromosome Location | chr6:26909641-26916801 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4634448 | chr6:26911653-26911654 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs144419540 | chr6:26911791-26911792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183722185 | chr6:26911885-26911886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576125795 | chr6:26911886-26911887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189111856 | chr6:26912005-26912006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542515832 | chr6:26912022-26912023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562247649 | chr6:26912028-26912029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs527846041 | chr6:26912040-26912041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541305288 | chr6:26912111-26912112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564603122 | chr6:26912120-26912121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4351253 | chr6:26912135-26912136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564808484 | chr6:26912210-26912211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114321449 | chr6:26912231-26912232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569687129 | chr6:26912250-26912251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4351255 | chr6:26912307-26912308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4278004 | chr6:26912325-26912326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529252467 | chr6:26912421-26912422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs202133022 | chr6:26912499-26912500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184189939 | chr6:26914219-26914220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188178142 | chr6:26914245-26914246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542989761 | chr6:26914394-26914395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559456009 | chr6:26914415-26914416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs180974875 | chr6:26914420-26914421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs6917814 | chr6:26914425-26914426 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs564384141 | chr6:26914554-26914555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565233123 | chr6:26914567-26914568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10946881 | chr6:26914611-26914612 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs7755054 | chr6:26914643-26914644 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs569747893 | chr6:26914684-26914685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12182270 | chr6:26914697-26914698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21509527 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26911600-26912600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:26914200-26914800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |